# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cronos Group Inc., (NASDAQ: CRON) a global cannabinoid company, has reported an increase in net revenue for the first quarter o...
Cronos Group (NASDAQ:CRON) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The compan...
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) announced on Tuesday that it's expanding its medical brand, PEACE NATURALS, in...
https://twitter.com/KevinSabet/status/1787569052782846142
https://www.marijuanamoment.net/florida-gop-formally-opposes-marijuana-legalization-ballot-initiative-clearing-path-for-desanti...
https://www.wsj.com/finance/regulation/declassifying-cannabis-still-leaves-pot-stocks-in-limbo-26d417ec
https://www.marijuanamoment.net/schumer-says-dea-marijuana-rescheduling-decision-is-historic-but-he-remains-strongly-committed-...